Agata Jarmuz
Lodz, LD, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome.
Journal: Pharmacological reports : PR
Published: August 24, 2016
Review: The Role of MOP and DOP Receptors in Treatment of Diarrheapredominant Irritable Bowel Syndrome.
Journal: Mini reviews in medicinal chemistry
Published: January 14, 2016
Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: December 15, 2015
Mixed MOP/DOP agonist biphalin elicits anti-transit effect in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms.
Journal: Pharmacological reports : PR
Published: April 16, 2015
Anti-inflammatory effect of dual nociceptin and opioid receptor agonist, BU08070, in experimental colitis in mice.
Journal: European journal of pharmacology
Published: April 10, 2015
Role of transient receptor potential channels in intestinal inflammation and visceral pain: novel targets in inflammatory bowel diseases.
Journal: Inflammatory bowel diseases
Published: December 02, 2014
Emerging treatments in Neurogastroenterology: Perspectives of guanylyl cyclase C agonists use in functional gastrointestinal disorders and inflammatory bowel diseases.
Journal: Neurogastroenterology and motility
Published: November 17, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026